Published in Biochem Biophys Res Commun on August 13, 1979
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother (1987) 2.24
Ribavirin causes error catastrophe during Hantaan virus replication. J Virol (2003) 1.78
Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother (1986) 1.72
Replicon system for Lassa virus. J Virol (2004) 1.69
Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob Agents Chemother (2000) 1.58
Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin. Antimicrob Agents Chemother (1983) 1.35
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob Agents Chemother (1983) 1.33
Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds. Antimicrob Agents Chemother (1991) 1.30
Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev (2000) 1.30
Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob Agents Chemother (1992) 1.24
In vitro and in vivo Phlebovirus inhibition by ribavirin. Antimicrob Agents Chemother (1988) 1.23
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leuk Lymphoma (2010) 1.20
Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction. Antimicrob Agents Chemother (1989) 1.15
Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro. Antimicrob Agents Chemother (1988) 1.14
Specific targets for antiviral drugs. Biochem J (1982) 1.11
Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells. Antimicrob Agents Chemother (1986) 1.10
Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol (2009) 1.07
Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob Agents Chemother (1986) 1.06
Inhibition of Borna disease virus replication by ribavirin. J Virol (1999) 1.05
Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrob Agents Chemother (2006) 1.04
Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. Antimicrob Agents Chemother (1987) 1.04
Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription. Antimicrob Agents Chemother (1988) 1.03
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity. Antimicrob Agents Chemother (1982) 1.01
Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: adenosine deaminase catalyzes two consecutive deamination reactions. Antimicrob Agents Chemother (2003) 0.98
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis (2014) 0.97
Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice. Antimicrob Agents Chemother (1981) 0.97
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A. PLoS One (2011) 0.94
Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap. RNA (2005) 0.90
Mechanism of action of ribavirin in the treatment of chronic hepatitis C. Gastroenterol Hepatol (N Y) (2007) 0.89
Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication. J Virol (1989) 0.86
Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes. Antimicrob Agents Chemother (2005) 0.86
Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin. Antimicrob Agents Chemother (1984) 0.85
Inhibition of lymphocyte proliferative responses by ribavirin. Infect Immun (1980) 0.85
Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells. Antimicrob Agents Chemother (1981) 0.84
Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol (2011) 0.83
Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes. PLoS Pathog (2015) 0.83
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis. PLoS One (2013) 0.81
Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats. Antimicrob Agents Chemother (2002) 0.81
The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment. J Virol (2013) 0.78
Novel Characteristics of Trypanosoma brucei Guanosine 5'-monophosphate Reductase Distinct from Host Animals. PLoS Negl Trop Dis (2016) 0.77
Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses (2016) 0.76
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir. PLoS One (2016) 0.75
Progress of small molecular inhibitors in the development of anti-influenza virus agents. Theranostics (2017) 0.75
Determining Ribavirin's mechanism of action against Lassa virus infection. Sci Rep (2017) 0.75
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer (2001) 6.16
Overlapping genes at the cheA locus of Escherichia coli. Proc Natl Acad Sci U S A (1980) 4.82
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet (2000) 3.76
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J (1993) 3.11
American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin (1997) 2.89
Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem (1987) 2.74
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature (1981) 2.71
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology (2004) 2.26
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr (1997) 2.24
Probing proton dynamics in molecules on an attosecond time scale. Science (2006) 2.24
Lymphedema: current issues in research and management. CA Cancer J Clin (2000) 2.21
Pressure support ventilation decreases inspiratory work of breathing during general anesthesia and spontaneous ventilation. Anesth Analg (1992) 2.14
Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer (1995) 2.13
Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens. Infect Immun (1972) 1.99
A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 and older. Public Health Rep (1991) 1.97
Determination of inorganic phosphate in the presence of labile organic phosphates. Anal Biochem (1969) 1.89
On the nature of the deoxyribonucleic acid methylases. Biological evidence for the multiple nature of the enzymes. Biochemistry (1965) 1.87
The active form of tumor necrosis factor is a trimer. J Biol Chem (1987) 1.86
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res (1996) 1.84
Planning for the future: the experience of implementing a children's day assessment unit in a district general hospital. Arch Dis Child (1997) 1.83
Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev (2000) 1.82
The pressure reversal of general anesthesia and the critical volume hypothesis. Mol Pharmacol (1973) 1.79
Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin (1997) 1.75
Intranasal Teeth. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol (1979) 1.73
Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol (1988) 1.72
Comparing the quality of death for hospice and non-hospice cancer patients. Med Care (1988) 1.67
Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome. Chest (1989) 1.66
THE SPECIES VARIATION OF RNA METHYLASE. Proc Natl Acad Sci U S A (1963) 1.65
Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium. Infect Immun (1972) 1.64
TRNA methylases in tumors of animal and human origin. Proc Natl Acad Sci U S A (1966) 1.63
Methionine synthesis from 5'-methylthioadenosine in rat liver. J Biol Chem (1981) 1.63
Expression of calf prochymosin in Saccharomyces cerevisiae. Gene (1984) 1.61
Heterologous protein secretion from yeast. Science (1985) 1.58
Expression cloning and signaling properties of the rat glucagon receptor. Science (1993) 1.54
Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology (1972) 1.53
Lysogenic induction. Prog Nucleic Acid Res Mol Biol (1973) 1.52
Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer (1989) 1.51
Cystic ameloblastoma--behavior and treatment of 21 cases. J Oral Maxillofac Surg (2001) 1.51
Techniques in the detection and characterization of phosphoramidate-containing proteins. Methods Enzymol (1984) 1.50
Escherichia coli O157 in feedlot cattle feces and water in four major feeder-cattle states in the USA. Prev Vet Med (2003) 1.49
American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin (1997) 1.48
The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci U S A (1974) 1.48
Quantitative high-performance liquid chromatography of nucleosides in biological materials. J Chromatogr (1978) 1.48
Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res (1992) 1.45
NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding protein. J Mol Biol (1997) 1.45
Direct demonstration of retroviral recombination in a rhesus monkey. J Virol (1997) 1.41
Intermittent CPAP: a new mode of ventilation during general anesthesia. Anesthesiology (1998) 1.41
Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. J Biol Chem (1986) 1.40
Development and verification of a schistosomiasis transmission model. Am J Trop Med Hyg (1977) 1.39
The roles of patient and observer assessments in anti-emetic trials. Eur J Cancer (1994) 1.39
Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci (1989) 1.38
Saskatchewan. Acute mustard seed toxicosis in beef cattle. Can Vet J (1989) 1.37
THE MECHANISM OF BACTERIAL FRAGILITY PRODUCED BY 5-FLUOROURACIL: THE ACCUMULATION OF CELL WALL PRECURSORS. Proc Natl Acad Sci U S A (1960) 1.37
High turnover rate of transfer RNA in tumor tissue. Cancer Res (1977) 1.37
Canine ventricular arrhythmias in the late myocardial infarction period. 8. Epicardial mapping of reentrant circuits. Circ Res (1981) 1.36
Tumour-specific phenylalanine tRNA contains two supernumerary methylated bases. Nature (1978) 1.35
Differences in the transfer RNA's of normal liver and Novikoff hepatoma. Proc Natl Acad Sci U S A (1969) 1.35
A self report measure of affective lability. J Neurol Neurosurg Psychiatry (1997) 1.35
Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen (2004) 1.31
Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J (2008) 1.31
Enzymatic alteration of macromolecular structure. Prog Nucleic Acid Res Mol Biol (1966) 1.30
Maxillary sinus complications related to endosseous implants. Int J Oral Maxillofac Implants (1995) 1.30
The mammography audit: a primer for the mammography quality standards act (MQSA). AJR Am J Roentgenol (1995) 1.29
Alterations in the transfer ribonucleic acid methylases after bacteriophage infection or induction. Biochemistry (1965) 1.28
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
The online patient meeting. J Neurol Sci (1996) 1.26
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet (2005) 1.26
Risk factors for impaired healing of the perineal wound after abdominoperineal resection of rectum for carcinoma. Colorectal Dis (2007) 1.25
A strategy for health manpower. Reflections on an experience called MEDEX. JAMA (1971) 1.25
Water-Quality Trends in the Nation's Rivers. Science (1987) 1.24
Detecting and reporting medical errors: why the dilemma? BMJ (2000) 1.23
Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res (2001) 1.23
The relaxed control phenomenon. Prog Nucleic Acid Res Mol Biol (1971) 1.21
Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer (1989) 1.21
Luminance-dependent changes in mesopic visual contrast sensitivity. J Physiol (1973) 1.21
Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5'-methylthioadenosine. J Biol Chem (1982) 1.21
AN EARLY PHASE IN THE BACTERICIDAL ACTION OF 5-FLUOROURACIL ON E. COLI K(12). OSMOTIC IMBALANCE. Proc Natl Acad Sci U S A (1959) 1.20
The solubility of anesthetic gases in lipid bilayers. Biochim Biophys Acta (1981) 1.20
Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg (1979) 1.19
Symptomatic care of patients with amyotrophic lateral sclerosis. JAMA (1975) 1.18
Long-term clinical follow-up after operation for lung carcinoma. Thorax (1970) 1.18
Atrial fibrillation in the preexcitation syndrome. Am J Cardiol (1977) 1.18
A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology. Arch Intern Med (1990) 1.18
Transfer RNA and transfer RNA modification in differentiation and neoplasia. Introduction. Cancer Res (1971) 1.17
Deoxyribonucleic acid methylase of mammalian tissues. Biochemistry (1968) 1.17
Arachnoid cysts of the middle cranial fossa. Surg Neurol (1976) 1.17
The tRNA methyltransferases. Adv Enzymol Relat Areas Mol Biol (1972) 1.15
Second primary lung carcinoma. Thorax (1976) 1.15
Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis. Thromb Haemost (1982) 1.14
Human interleukin 4. The solution structure of a four-helix bundle protein. J Mol Biol (1992) 1.14
Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases. Biochemistry (1991) 1.14